Literature DB >> 16013091

A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets.

Roland Orre1, Andrew Bate, G Niklas Norén, Erik Swahn, Stefan Arnborg, I Ralph Edwards.   

Abstract

A recurrent neural network, modified to handle highly incomplete training data is described. Unsupervised pattern recognition is demonstrated in the WHO database of adverse drug reactions. Comparison is made to a well established method, AutoClass, and the performances of both methods is investigated on simulated data. The neural network method performs comparably to AutoClass in simulated data, and better than AutoClass in real world data. With its better scaling properties, the neural network is a promising tool for unsupervised pattern recognition in huge databases of incomplete observations.

Mesh:

Substances:

Year:  2005        PMID: 16013091     DOI: 10.1142/S0129065705000219

Source DB:  PubMed          Journal:  Int J Neural Syst        ISSN: 0129-0657            Impact factor:   5.866


  6 in total

1.  Bayesian confidence propagation neural network.

Authors:  Andrew Bate
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources.

Authors:  Gianluca Trifirò; Janet Sultana; Andrew Bate
Journal:  Drug Saf       Date:  2018-02       Impact factor: 5.606

3.  An Implementation and Visualization of the Tree-Based Scan Statistic for Safety Event Monitoring in Longitudinal Electronic Health Data.

Authors:  Stephen E Schachterle; Sharon Hurley; Qing Liu; Kenneth R Petronis; Andrew Bate
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

4.  Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).

Authors:  Manfred Hauben; Lester Reich; Charles M Gerrits; David Madigan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Sources of Safety Data and Statistical Strategies for Design and Analysis: Postmarket Surveillance.

Authors:  Rima Izem; Matilde Sanchez-Kam; Haijun Ma; Richard Zink; Yueqin Zhao
Journal:  Ther Innov Regul Sci       Date:  2018-01-08       Impact factor: 1.778

6.  Artificial Intelligence, Real-World Automation and the Safety of Medicines.

Authors:  Andrew Bate; Steve F Hobbiger
Journal:  Drug Saf       Date:  2020-10-07       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.